On the occasion of BioEurope 2009 in Vienna, Europe’s most important Pharma and Biotech partnering conference, Redbiotec presented its proprietary and cutting-edge protein expression technologies to the international community. Important contacts were established with leading Pharma and Biotech companies. Redbiotec is now in advanced negotiations with several of these regarding the use of its technologies for vaccine development and drug discovery. Redbiotec will also be present at the follow-on conference, BioEurope Spring 2010, in Barcelona.